This paper suggested PLD1 inhibition as a potential therapeutic strategy for glioblastoma, showing this approach as more beneficial when used in combination with the administration of TMZ, compared to treatment with TMZ alone [49]. This evidence concerns the gene PLD1 and glioblastoma.